Coherus BioSciences, Inc. - COM (CHRS)

Historical Portfolio Holders from Q4 2014 to Q2 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / COM
Shares, excl. options Q1 2024
81.6 M
Holdings value Q1 2024
$195 M
Value change Q1 2024
-$6.84 M
Grand Portfolio weight change Q1 2024
0%
Number of holders
130
Number of buys Q1 2024
2
Number of sells Q1 2024
-1
Average buys Q1 2024 %
+0%
Average sells Q1 2024 %
0%
CUSIP
19249H103
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q2 165 K $285 K +$191 K $1.73 4
2024 Q1 81.6 M $195 M -$6.84 M $2.39 130
2023 Q4 81.3 M $271 M -$40 M $3.33 155
2023 Q3 92.9 M $348 M +$20.1 M $3.74 167
2023 Q2 86.7 M $370 M +$29.2 M $4.27 160
2023 Q1 78.4 M $536 M -$1.64 M $6.84 166
2022 Q4 78.6 M $623 M +$4.04 M $7.92 162
2022 Q3 76.9 M $739 M -$11.4 M $9.61 165
2022 Q2 78.1 M $566 M +$17.6 M $7.24 170
2022 Q1 75.5 M $973 M -$14.6 M $12.91 172
2021 Q4 75.9 M $1.21 B +$10.8 M $15.96 190
2021 Q3 74.8 M $1.2 B -$20.6 M $16.07 179
2021 Q2 76.9 M $1.06 B -$38.1 M $13.83 181
2021 Q1 79.4 M $1.16 B -$124 M $14.61 200
2020 Q4 86.7 M $1.51 B +$6.89 M $17.38 188
2020 Q3 87.6 M $1.61 B -$15.5 M $18.34 198
2020 Q2 86.5 M $1.54 B +$229 M $17.86 185
2020 Q1 74.1 M $1.2 B +$17.4 M $16.22 181
2019 Q4 72.2 M $1.3 B +$60 M $18.00 181
2019 Q3 68.8 M $1.39 B +$50.1 M $20.26 161
2019 Q2 66.3 M $1.46 B +$24 M $22.10 141
2019 Q1 68.7 M $937 M +$44 M $13.64 113
2018 Q4 65.7 M $594 M +$3.13 M $9.05 107
2018 Q3 57.1 M $943 M +$35.9 M $16.50 105
2018 Q2 61.9 M $866 M +$96.3 M $14.00 113
2018 Q1 55.3 M $611 M +$32.9 M $11.05 102
2017 Q4 49.5 M $435 M +$17.2 M $8.80 93
2017 Q3 46.9 M $626 M +$87.2 M $13.35 90
2017 Q2 40.1 M $576 M +$26.8 M $14.35 106
2017 Q1 37.3 M $789 M +$211 M $21.15 111
2016 Q4 29.9 M $842 M +$50.9 M $28.15 121
2016 Q3 27.8 M $743 M +$77 M $26.78 115
2016 Q2 25.3 M $428 M +$112 M $16.89 85
2016 Q1 18.2 M $387 M +$29.1 M $21.23 74
2015 Q4 16.7 M $384 M +$8.77 M $22.96 77
2015 Q3 15.8 M $317 M +$14.2 M $20.04 76
2015 Q2 14.9 M $431 M +$223 M $28.90 71
2015 Q1 7.27 M $222 M -$28.1 M $30.58 49
2014 Q4 9.85 M $158 M +$158 M $16.32 37